🔗 Permalink

Inventor profile of:

Eugene R. Cooper

City:

Berwyn, Pennsylvania

Country:

United States

Published Applications:

Last publication date:

2022-10-20

Top Assignees for applications by Eugene R. Cooper

The entities that hold a legal rights for patent applications filed by inventor Cooper Eugene R.:

MacuSight, Inc. 6 Union City, CA United States
Juventio, LLC 3 Chatham, NJ United States
Thompson Cooper Laboratories, LLC 3 Horsham, PA United States
ALKERMES PHARMA IRELAND LIMITED 2 Dublin, Ireland
Recro Pharma, Inc. 2 Malvern, PA United States
DERMWORX, INC. 2 Hollywood, FL United States
Elan Pharma International Ltd. 2 Dublin, Ireland
DermWorx Incorporated 2 Hollywood, FL United States
Alkermes Pharma Ireland Limited 1 County Westmeath, Ireland
Eyeon Particle Sciences LLC 1 Rochester, NY United States
ELAN PHARMA INTERNATIONAL LIMITED 1 Monksland Athlone, County Westmeath, Ireland
DermWorx Incorporated 1 Hallandale, FL United States
Elan Pharma International Limited 1 Athlone, County Westmeath, Ireland
Elan Pharma International Ltd. 1 Shannon, Ireland
Elan Pharma International Ltd. 1 Athlone County Westmeath, Ireland
Santen Pharmaceutical Co., Ltd. 1 Osaka, Japan
BAUDAX BIO, INC. 1 Malvern, PA United States
Elan Pharma International, Ltd. 1 County Clare, Ireland

Recent patent applications by Cooper Eugene R.

Eugene R. Cooper from Berwyn, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-10-20

US20220331269A1

Human necessities

COMPOSITIONS FOR TREATING ACNE

#2 | 2021-12-30

US20210401768A1

Human necessities

FORMULATIONS OF CANNABINOIDS FOR THE TREATMENT OF DERMATITIS AND INFLAMMATORY SKIN DISEASES

#3 | 2021-04-22

US20210113580A1

Human necessities

NANOPARTICULATE MELOXICAM FORMULATIONS

#4 | 2020-05-21

US20200155564A1

Human necessities

Nanoparticulate Meloxicam Formulations

#5 | 2020-01-23

US20200022927A1

Human necessities

COMPOSITIONS FOR TREATING ACNE

#6 | 2020-01-09

US20200009253A1

Human necessities

Compositions and Methods for Treatment of Infections

#7 | 2019-12-19

US20190381062A1

Human necessities

Nanoparticulate meloxicam formulations

#8 | 2018-08-16

US20180228810A1

Human necessities

Nanoparticulate Meloxicam Formulations

#9 | 2018-08-16

US20180228809A1

Human necessities

Nanoparticulate meloxicam formulations

#10 | 2017-06-08

US20170157061A1

Human necessities

Nanoparticulate meloxicam formulations

#11 | 2014-07-17

US20140199249A1

Human necessities

Compositions for depositing agents using highly volatile silicone solvents

#12 | 2014-05-22

US20140141083A1

Human necessities

NANOPARTICULATE MELOXICAM FORMULATIONS

#13 | 2014-04-24

US20140112980A1

Human necessities

ABUSE-RESISTANT PHARMACEUTICAL COMPOSITIONS

#14 | 2014-03-20

US20140079804A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF INFECTIONS

#15 | 2014-02-13

US20140044658A1

Human necessities

Compositions and Methods for Treatment of Infections

#16 | 2013-08-20

US10784900

Nanoparticulate meloxicam formulations

#17 | 2012-08-23

US20120213829A1

Human necessities

DRY POWDER AEROSOLS OF NANOPARTICULATE DRUGS

#18 | 2012-02-09

US20120034279A1

Human necessities

TRANSSCLERAL DELIVERY

#19 | 2011-07-21

US20110177169A1

Human necessities

OPHTHALMIC FORMULATIONS OF REVERSED LIQUID CRYSTALLINE PHASE MATERIALS AND METHODS OF USING

#20 | 2011-02-03

US20110027371A1

Human necessities

Nanoparticulate statin formulations and novel statin combinations

#21 | 2010-11-25

US20100297252A1

Human necessities

NANOPARTICULATE MELOXICAM FORMULATIONS

#22 | 2010-09-09

US20100226963A1

Human necessities

Bi-functional co-polymer use for opthalmic and other topical and local applications

#23 | 2010-07-27

US10457811

Nanoparticulate polycosanol formulations and novel polycosanol combinations

#24 | 2010-07-15

US20100178648A1

Human necessities

In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions

#25 | 2010-06-10

US20100143962A1

Human necessities

NANOPARTICULATE POLYCOSANOL FORMULATIONS & NOVEL POLYCOSANOL COMBINATIONS

#26 | 2010-01-21

US20100016442A1

Human necessities

Small molecule solubilization system

#27 | 2009-12-31

US20090324690A1

Human necessities

TRANSSCLERAL DELIVERY

#28 | 2009-12-31

US20090324689A1

Human necessities

TRANSSCLERAL DELIVERY

#29 | 2009-12-31

US20090324688A1

Human necessities

TRANSSCLERAL DELIVERY

#30 | 2009-12-31

US20090324687A1

Human necessities

TRANSSCLERAL DELIVERY

#31 | 2009-12-31

US20090324686A1

Human necessities

TRANSSCLERAL DELIVERY

#32 | 2009-07-30

US20090192125A1

Human necessities

Local anti-infective agent for treatment of nail fungal infections

#33 | 2009-07-16

US20090181100A1

Human necessities

Propellant-based nanoparticulate dry powder aerosols and method of making

#34 | 2009-04-21

US9190138

Dry powder aerosols of nanoparticulate drugs

#35 | 2009-02-19

US20090048347A1

Human necessities

Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic

#36 | 2008-09-04

US20080213378A1

Human necessities

Nanoparticulate statin formulations and novel statin combinations

#37 | 2008-08-14

US20080193508A1

Human necessities

Local anti-infective agent for treatment of nail fungal infections

#38 | 2008-07-24

US20080176948A1

Human necessities

Topical anesthetic for rapid local anesthesia

#39 | 2008-06-24

US10766960

Nanoparticulate topiramate formulations

#40 | 2007-05-17

US20070110776A1

Human necessities

In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions

#41 | 2007-04-03

US10323736

methods for evaluating the effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions

#42 | 2006-05-18

US20060104909A1

Human necessities

Abuse-resistant pharmaceutical compositions

#43 | 2005-06-21

US10268928

Compositions having a combination of immediate release and controlled release characteristics

#44 | 2005-03-24

US20050064010A1

Human necessities

Transscleral delivery

InventorID:

649754 ⎘